ASTEC — Astec Lifesciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹24.36bn
- IN₹28.63bn
- IN₹6.28bn
Annual cashflow statement for Astec Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 559 | 614 | 891 | 1,211 | 349 |
| Depreciation | |||||
| Non-Cash Items | 110 | 143 | 34.4 | 73.7 | 169 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -710 | 696 | -1,264 | -1,393 | -108 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 153 | 1,684 | -82 | 236 | 747 |
| Capital Expenditures | -528 | -453 | -1,025 | -1,040 | -1,173 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 2.76 | -285 | 294 | 1.12 | 47.5 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -525 | -738 | -731 | -1,039 | -1,125 |
| Financing Cash Flow Items | -124 | -129 | -47.5 | -89.1 | -201 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 371 | -945 | 813 | 805 | 378 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.19 | 0.958 | 0.308 | 2.16 | -0.811 |